RSS
women’s health
Forendo Pharma raises additional funding to accelerate development of women’s health portfolio
Clinical stage drug development company, Forendo Pharma, has raised an additional €4 million of funding from Vesalius Biocapital III Partners, which will be used with other raised funds to accelerate the development of its women’s health portfolio. Read more
Theramex and Endoceutics agree on exclusive licensing of Intrarosa in specific countries
Global specialty pharma company, Theramex, and private pharma company, Endoceutics, have entered into a definitive agreement for the exclusive licensing of Intrarosa (Prasterone) in Europe, Australia, Russia and the Ukraine. Read more
New pharma company dedicated to women and their health launches
A new speciality pharmaceutical company dedicated to women and their health has been launched through CVC Fund VI’s acquisition of Teva Pharmaceutical Industries international women’s health assets. Read more
